Cancer

Cancer biology is advancing fast – but does America’s “moonshot” to cure cancer fit the bill?

Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.

How can we get cytotoxic drugs through the blood–brain barrier – without permanent damage?

Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.

“Extraordinary” results from a T-cell therapy trial offer hope to leukemia patients – and to researchers toiling in unfashionable fields.

What can Drosophila eyes tell us about the origins of cancer?

How can we get drugs to the liver to treat its dysfunction, without making it worse?

Like many drugs today, pembrolizumab (Keytruda) was the result of a group effort. Here, we catch up with two scientists who shaped the destiny of the biotherapeutic at very different stages in its development.

It’s often difficult to target pancreatic cancer cells while sparing healthy tissue – but a new therapy concept not only makes this possible, but also enhances the potential effectiveness of adjuvant treatments

When genetics yielded unsatisfactory answers about pancreatic cancer’s persistent survival, researchers looked beyond the genome – and found telling epigenetic changes